Ozempic: How it really works, what they don't tell you, and how to naturally boost GLP-1.
- Aug 17
- 8 min read
Ozempic has become the most talked-about drug of recent years. Some are calling it the weight-loss revolution. Others—including an increasing number of doctors—are starting to ask uncomfortable questions about what happens next. This article isn't against Ozempic. It's an honest explanation of how it really works, why it might not be enough on its own, and what you can do to achieve similar effects without an injection.
60-second summary:
Ozempic (semaglutide) is a GLP-1 agonist — a drug that mimics the gut hormone GLP-1, which is responsible for satiety, blood sugar regulation, and fat metabolism.
It works : It can cause 15-20% body weight loss in clinical studies. Its effectiveness is beyond question.
What almost no one says: up to 40% of the weight lost is muscle mass, not fat. And those who stop taking it regain an average of two-thirds of the weight lost within 12 months.
The real problem is not the drug itself — it is its use without altering the metabolic and behavioral substrate that the drug has covered.
Your body produces GLP-1 naturally . With the right dietary stimulation, you can significantly increase this production—without injections. It's less potent than medication, but it doesn't have the side effects, and best of all, you never stop taking it because your gut produces it.
GLP-1: The Hormone Ozempic Mimics
GLP-1 stands for Glucagon-Like Peptide-1 —a hormone produced by the L-cells in the intestine in response to food intake. It's not an exotic or synthetic hormone: your body already produces it every time you eat.
Its main functions:
It stimulates insulin secretion in a glucose-dependent manner (only when blood sugar is high — a much safer mechanism than older hypoglycemic drugs)
It inhibits glucagon , the hormone that raises blood sugar levels by releasing sugars from the liver
It slows gastric emptying , increasing the feeling of satiety after meals
It acts on the hypothalamus, reducing appetite at a central level
It promotes fat oxidation and has documented cardioprotective effects
The problem: Natural GLP-1 has a half-life of 1–2 minutes . It's rapidly degraded by the DPP-4 enzyme. Semaglutide (Ozempic) is a chemically modified version that lasts a full week —that's why a weekly injection is enough. It's this persistence that makes it so powerful. And it's this persistence that causes problems when you stop taking it.
How does Ozempic work?
Ozempic is not a diet pill. It is a GLP-1 receptor agonist : it binds to the same receptors as natural GLP-1, but remains active much longer. The result is prolonged appetite suppression, more stable blood sugar levels, and reduced food cravings.
The effect on weight is real and documented: in the main clinical trials (SUSTAIN, STEP), patients treated with semaglutide lost an average of 15-20% of their body weight in 68 weeks. These figures are unmatched by any diet in the general population.
It is indicated for: type 2 diabetes (Ozempic, AIFA approved), obesity with a BMI ≥30 or overweight with a BMI ≥27 associated with comorbidities (Wegovy, higher dose). Use for simple cosmetic weight loss in normal weight or mildly overweight individuals is off-label and not recommended.
3 side effects that few people explain
1. Up to 40% of weight lost is muscle, not fat
This is the most underappreciated finding—and the most concerning from a longevity perspective. Studies show that a significant portion of weight loss with semaglutide—estimated between 25 and 40%—relates to lean mass , not visceral fat.
Losing 15 kg with Ozempic can mean losing 5-6 kg of muscle. Muscle mass is the body's primary glucose scavenger, the main metabolic organ, and the main predictor of longevity and functional autonomy after age 60. Losing it isn't a minor side effect—it's a serious metabolic problem.
The documented countermeasure is strength training during therapy and a high protein intake. Those who take Ozempic without a resistance training program are optimizing their weight on the scale, not their body composition.
2. Most of the weight is recovered during suspension
A study published in Diabetes, Obesity and Metabolism (2022) followed patients for a year after stopping semaglutide: on average, they regained 65–70% of the weight they had lost within 12 months. This wasn't because they lacked willpower—but because the biological mechanisms that controlled appetite had been controlled by the drug, not re-educated.
This doesn't mean Ozempic is useless. It just means that using it without simultaneously modifying your diet, microbiota, and behavioral habits is like renting the solution instead of buying it. It works as long as you pay the rent.
3. Basal metabolism decreases
Loss of muscle mass reduces your basal metabolic rate—the amount of calories you burn at rest. If you resume your previous eating habits (even the same calories as before) after treatment, the body with less muscle burns less. The weight regained is more easily stored than before the drug , and almost entirely as fat.
Please note: There are also frequent gastrointestinal side effects (nausea, diarrhea, vomiting—present in 16-20% of patients in the SELECT study), rare cases of pancreatitis, and absolute contraindications in those with a personal or family history of medullary thyroid cancer. And the cost is not trivial: €500-700/month at weight-loss doses.
Natural GLP-1: How Your Gut Can Make More of It
Here's the most interesting angle from a functional nutrition perspective. Your body already produces GLP-1. The problem is that production is often suboptimal—due to an altered microbiota, a diet low in fiber and protein, and an ultra-processed diet that doesn't adequately stimulate intestinal L cells.
Research in recent years shows that specific nutrients and dietary habits significantly stimulate GLP-1 secretion. Not to the same extent as the drug —that remains more potent. But it has an advantage that the drug cannot: it never stops being produced, it costs nothing, and it has no side effects.
1 - Protein at every meal
Protein is the nutrient that most effectively stimulates the release of GLP-1 from L-cells. Specifically, amino acids such as leucine, arginine, and lysine directly activate receptors on intestinal L-cells. The effect is dose-dependent: the more protein, the more GLP-1.
Optimal sources: eggs, fish (especially oily fish), lean white meat, legumes, Greek yogurt, ricotta, whey protein.
Practical goal: 1.2-1.6g of protein per kg of body weight per day , evenly distributed between meals — not concentrated in a single meal.
2 - Good fats: salmon, nuts, avocado, extra virgin olive oil
Unsaturated fats—particularly omega-3 and monounsaturated fatty acids —stimulate the release of GLP-1 through the GPR120 and GPR40 receptors on L-cells. The effect of extra virgin olive oil has been specifically documented: one study showed that EVOO increases postprandial GLP-1 concentrations more than other vegetable oils , including sunflower and soybean oil.
Optimal sources: wild salmon, mackerel, sardines, walnuts, almonds, avocado, raw EVO oil.
3 - Soluble fibers: the substrate that feeds the L cells
Soluble fiber is fermented by the gut microbiota, producing short-chain fatty acids (SCFAs) —propionate and butyrate in particular. These SCFAs bind directly to the GPR41 and GPR43 receptors on L-cells, stimulating the release of GLP-1. This is the most effective mechanism for increasing endogenous production in the colon.
Optimal sources: oats, barley, legumes (lentils, chickpeas, beans), apples, pears, broccoli, artichokes, chicory. The goal is 25-30g of total fiber per day, at least half of which must be soluble.
4 - Healthy microbiota: fermented foods and green tea
The gut microbiota is the driving force behind GLP-1 production via SCFAs. The most relevant bacterial strains for this mechanism include Akkermansia muciniphila, Bifidobacterium spp., and Lactobacillus spp. —bacteria that thrive on a diet rich in fiber and fermented foods.
Green tea contributes through a different mechanism: catechins (EGCG in particular) inhibit DPP-4—the enzyme that breaks down natural GLP-1—prolonging its action. This mechanism is similar to that of gliptin drugs (sitagliptin, saxagliptin), but in a much milder form and without side effects.
Optimal sources: kefir, Greek yogurt with live cultures, kombucha, sauerkraut, kimchi, green tea (2-3 cups daily, not in capsules).
Drug vs. Natural Approach
Potency: Semaglutide is much more potent. Period. It's nonsense to claim otherwise.
Duration of effect: Natural GLP-1 lasts 1-2 minutes; the drug lasts a week. The advantage of natural GLP-1 is that it is produced continuously, after every meal, without interruptions.
Side effects: The nutritional approach has no side effects. The drug has been associated with nausea, diarrhea, muscle loss, high cost, and rebound upon discontinuation.
Sustainability: The nutritional approach is permanent—you build a system that works on its own. Medication is temporary—unless you take it forever.
Clinical indications: In severe obesity, type 2 diabetes, and high cardiovascular risk, the drug has a genuine clinical indication and a documented risk/benefit ratio. In these cases, it should not be demonized. It should be supported with adequate nutrition.
The point isn't to choose one over the other. It's to understand that the drug suppresses a symptom (excessive hunger) without addressing the cause (a metabolism and microbiota that don't produce enough endogenous GLP-1). The functional nutritional approach addresses the underlying cause.
Michela's Case Study
🙋🏼♀️ Michela, 50 years old: lost 20 kg in 6 months. Without Ozempic.
When she came to us, the problem wasn't just the weight.
There was unmanageable hunger, low energy, bloating, difficulty losing weight, and a metabolism that no longer responded as it should.
📖 What we did: We built a personalized protocol based on the GRN method with functional nutrition, carbohydrate management, more satiating meals, improved food quality, and ongoing support over time.
No shortcuts. No diet drugs.
✅ Result in 6 months: -20 kg, elimination of dyslipidemia, inflammation, and insulin resistance. She has more energy, better hunger control, greater body confidence, and a more peaceful relationship with food.
The point wasn't to eat less. It was to make my metabolism work better . 👉🏻 Discover all the testimonials HERE
Frequently Asked Questions about Ozempic and GLP-1
Can Ozempic be prescribed for weight loss without diabetes?
In Italy, Ozempic is approved only for type 2 diabetes . For obesity, there is Wegovy (same active ingredient, higher dosage), which has specific indications: BMI ≥30, or BMI ≥27 with at least one comorbidity (hypertension, dyslipidemia, sleep apnea). Off-label use in people of normal weight or mildly overweight is not recommended and is not reimbursed by the National Health Service.
How much does Ozempic cost per month?
At the doses used for weight loss (1-2 mg/week), the monthly cost varies between €500 and €700, which is not reimbursed by the NHS for non-diabetic indications. Wegovy has a similar cost. It's a significant investment, especially considering that the weight tends to return after stopping.
Can you take Ozempic and work on natural GLP-1 at the same time?
Yes—and it's the most correct approach. Those undergoing semaglutide therapy should simultaneously work on protein, fiber, the microbiota, and strength training. This way, when the drug is discontinued, the endogenous GLP-1 production system is more robust, muscle mass is preserved, and weight gain is reduced.
Does green tea replace medicine?
No. The DPP-4 inhibition by green tea catechins is much weaker than that of gliptins or the effect of semaglutide. Green tea is a useful adjunct to a comprehensive nutritional approach, not a replacement for medication.
Want to optimize your natural GLP-1 with a customized protocol?
The Body Check analyzes your metabolic, insulin, and gut health profile in 40 minutes online. Together, we'll create a nutritional plan that stimulates endogenous GLP-1 production, protects muscle mass, and addresses the causes of excess weight— not the symptoms.
Completely skipped from the route if you decide to continue.
📚 Scientific sources
Wilding JPH et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine, 2021 (STEP 1 trial).
Bhatta M et al. "Weight regaining after stopping semaglutide." Diabetes, Obesity and Metabolism, 2022.
Ryan DH et al. "Semaglutide effects on cardiovascular outcomes in people with overweight or obesity." NEJM (SELECT), 2023.
Holst JJ. “The physiology of glucagon-like peptide 1.” Physiological Reviews, 2007.
Paniagua JA. "Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome." World Journal of Diabetes, 2016.
Paniagua JA et al. "Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects." Diabetes Care, 2007.
Cani PD et al. "Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability." Gut, 2009.
AIFA. Ozempic (semaglutide) data sheet. Italian Medicines Agency.
⚠️ Disclaimer
This article is for informational and educational purposes only. It does not constitute medical prescription or therapeutic advice. Ozempic and Wegovy are prescription-only drugs. Do not initiate, modify, or discontinue semaglutide therapy without the advice of your doctor or specialist. The data reported refer to the cited clinical studies and the AIFA technical data sheets.
Comments